Home Tags Abbott

Abbott

Abbott’s fourth COVID-19 test received FDA EUA

Abbott announced that FDA issued Emergency Use Authorization (EUA) for the company's SARS-CoV-2 IgG lab-based serology blood test on the Alinity™ i system. Abbott...

Abbott Intends to Achieve Production of 1M COVID-19 Testing Kits per Week

Abbott announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19)....

New Gallant ICD Had Received CE Mark

Abbott announced it has received CE Mark for the new Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices, bringing the...

In-development Fully Implantable Heart System Earns FDA’s Breakhrough Device Designation

Abbott announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left...

Abbott Scientists Identified New Subtype of Human Immunodeficiency Virus

Abbott announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L. The...
20,123FansLike
2,241FollowersFollow
2,275SubscribersSubscribe

Hot Topics

Three Russian Prototypes of COVID-19 Vaccine Prove Effective

Three Russian prototypes of the vaccine against COVID-19 have demonstrated their efficacy in a series of tests, Rinat Maksiutov, Director General of the State...

Extension of Deadlines for GMP Certificate Submission Approved by EAEU

Mechanisms for resolving disagreements arising from the registration of pharmaceuticals have been addressed by the Expert Committee for Medicines, created under the auspices of...

Veklury is the First Approved Treatment Option for COVID-19 in the European Union

Gilead Sciences, Inc. announced that the European Commission has granted conditional marketing authorization for Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus...